ECL vs TARS · P/E 35, rev $8.48B vs rev $336.0M
Ecolab Inc (ECL) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported ECL revenue for 2026-06-30 was $8.48B. Net income was $967.5M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. TARS currently screens at market cap $2.66B.
Not investment advice. Open the ECL and TARS stock pages for the full models.
Not investment advice.